Remission in Subjects With Crohn's Disease, 1 Year Phase

NCT00055497 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

BIOLOGICAL: Double-blind (DB) adalimumab placebo
BIOLOGICAL: DB adalimumab 40 mg eow
BIOLOGICAL: DB adalimumab 40 mg ew
BIOLOGICAL: OL adalimumab 40 mg

Sponsor

Abbott